Alex Braun; Head of Investor Relations; Acumen Pharmaceuticals Inc. Daniel O'Connell; Chief Executive Officer, Director; Acumen Pharmaceuticals Inc. W. Matthew Zuga; ...

A Connecticut investment firm is backing the Tampa brokerage with $95 million to launch the homebuilders insurance-focused exchange.

Q4 2024 Earnings Call Transcript March 25, 2025 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

Greetings and welcome to the X4 Pharmaceuticals fourth quarter and full year 2024 financial and operating results conference call. (Operator Instructions) and it is now my pleasure to turn to your ...

Friday is the third and final day of initial hearings for the more than two dozen men who authorities say are among the most ...

Thank you for standing by and welcome to the Corvus Pharmaceuticals fourth-quarter and full-year 2024 business update and financial results conference call. (Operator Instructions) It is now my ...

This came on the back of revenues totalling $7.7 billion, which is up by 8.9 per cent year on year. Read more at straitstimes ...

Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.

the competition from online retailers such as Ali-Health or JD Health as well as local operators is intense. We also don’t think CR Pharma’s manufacturing business has a moat. Its ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 98,935.61 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

Thank you for standing by, and welcome to the Corvus Pharmaceuticals Fourth Quarter and Full Year 2024 Business Update and Financial Results Conference Call. [Operator Instructions] It is now my ...

The developer of a spray-based erectile dysfunctional treatment, LTR Pharma has found a pre-approval route to the US market.